Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹314 Cr₹266 Cr₹185 Cr₹236 Cr₹117 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹314 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹314 Cr
Mar2023₹266 Cr
Mar2022₹185 Cr
Mar2021₹236 Cr
Mar2020₹117 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹314 Cr
17.80
Mar2023 ₹266 Cr
44.29
Mar2022 ₹185 Cr
-21.77
Mar2021 ₹236 Cr
101.62
Mar2020 ₹117 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,746.9 Cr -1.1% -14.6% 72.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1.1%

-14.6%

72.2%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses